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Available online at www.sciencedirect.comWhile viral latency remains one of the biggest challenges for
successful antiviral therapy, it has also inspired mathematical
modelers to develop dynamical system approaches with the
aim of predicting the impact of drug efficacy on disease
progression and the persistence of latent viral reservoirs. In this
review we present several differential equation models and
assess their relative success in giving advice to the working
clinician and their predictive power for inferring long term viral
eradication from short term abatement. Many models predict
that there is a considerable likelihood of viral rebound due to
continuous reseeding of latent reservoirs. Most mathematical
models of HIV latency suffer from being reductionist by ignoring
the growing variety of different cell types harboring latent virus,
the considerable intercellular delay involved in reactivation, and
host-related epigenetic modifications which may alter
considerably the dynamical system of immune cell populations.
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Introduction
Viral latency is a reversible state of nonproductively
infected host cells [1]. Once integrated in the nucleus
of the cell, the virus may remain dormant; that is, for
certain time periods no new virions are produced, but
nevertheless the inactivated viral genome remains poten-
tially harmful by virtue of host cell proliferation. For the
case of proviral latency, cytokine induction can activate
the virus from its dormant state [2] such that the provirus
enters the lytic infection cycle. Besides escape mutations
during the early infection phase [3–5], viral latency
Open access under CC BY-NC-ND license.Current Opinion in Virology 2013, 3:402–407 constitutes a major challenge for both efficient drug
treatment and mathematical modeling of infectious dis-
ease. In the present review we discuss mathematical
models that predict the size of viral reservoirs evolving
during the course of infection and their capability of
producing rebounds of viral load. We highlight the use
of differential equations (e.g. [6–9,10,11]) which have
proven to most successfully model the temporal dynamics
of molecular factors involved with latent viral infection.
Such models aim to make accurate predictions about the
efficacy of treatment administration.
Given the possibilities of deep sequencing [12] and the
better understanding of epigenetic factors involved in
latency [13], we also touch on new directions of modeling
the interplay of host-related epigenetic regulation and
evolving latent reservoirs in the context of therapy design.
Basic differential equations models of HIV
latency
Being the most prominent example of proviral latency, we
discuss in detail modeling approaches for HIV latency
(see Figure 1). The main reservoirs of latent HIV are
memory CD4+ T lymphocytes which harbor integrated
proviruses that are unable to complete their lifecycle [14].
Model compartments are given by the variables T, L, T*
and V: the number of susceptible, latently infected and
effectively infected CD4+ lymphocytes and viral load in
blood serum, respectively.
On the left-hand side of Eqn 1–4 (see [10,15] for model
parameters) there appear change rates of the variables
defined by (dT*/dt)(s)  (T*(s + D)  T*(s))/D for a short
time increment D > 0. On the right-hand side the so-
called incidence function F determines the interdepen-
dence of T cell and viral populations and their presumed
effect on the rate of change of T, T* and L (see Figure 2).
All variables are dependent upon time s, which is omitted
for notational convenience:
dT
dt
¼ a  FðT ; VÞ  dTT (1)
dL
dt
¼ hð1  eÞFðT ; VÞ  dLL  aLL (2)
dT 
dt
¼ ð1  hÞeFðT ; VÞ  dT T   aLL (3)
dV
dt
¼ pT   cV (4)
The model parameters are the recruitment rate of
susceptible T cells, a the rate of transition from latently
infected to productively infected cells aL, the cell deathwww.sciencedirect.com
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Basic cell compartments involved with HIV infection: susceptible T cells (T), effectively infected T cells (T*), latently infected T cells (L) and viremia due
to lytic viral replication (V).
Figure 2
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The incidence function F(T,V) quantifies to which extent the size of
susceptible T cell populations and viremia lead to reactivation.rates dT, dL and dT , the drug efficacy e, the fraction of
infection h leading to proviral latency, the viral clearance
rate c, and the virus production rate p. As an example we
discuss Eqn 2:
The incremental change of the latent viral reservoir dL/dT
is given by the product of viremia and susceptible T cells,
which means that assuming constant viremia, the latent
reservoir changes in linear dependence according to the
number of susceptible T cells. h being usually 103 [16],
only a few susceptible cells become latently infected, the
majority 1  h being effectively infected. Drug efficacy e
is set around 0.85, but since provirus is neither affected by
protease inhibition nor by antiretroviral drugs, it is the
inefficacy rate 1  e that affects the change rate of the
latent reservoir. Antigen presentation may reactivate
latent provirus such that aL = 0.1 latently infected cells
leave the reservoir. Memory CD4+ T cells also undergo
apoptosis with constant rate dL = 10
3.
F(T,V) = 1: Linear equations assume that the change rate
of plasma viremia and CD4+ T cells within a small
amount of time is proportional to their starting concen-
tration. In [17] it is shown that such a model can explain a
rebound of viral load despite a long period of declining
virus production. Because the pool of dormant virus has
considerable genomic variety [18], it is necessary to
introduce a continuous range of activation rates for the
provirus depending on the particular strain. Accessorywww.sciencedirect.com cells (such as macrophages) which are specific for rare
antigens have thus lower probability of being activated
and the mathematical model predicts a decelerating
decay of latently infected cells upon highly active anti-
retroviral therapy (HAART).Current Opinion in Virology 2013, 3:402–407
404 Viral genomicsF(T,V) = TV: Bilinear equations assume that the change
rate of the number of productively infected cells within a
small amount of time corresponds to the product of the
starting viremia and CD4+ T cell concentration. Solutions
to these equations have only one positive steady state of
viremia, which is very sensitive to small changes in drug
efficacy once it is close to its optimum [19]. The predicted
time to reach a steady state below the level of detect-
ability (50 copies/ml) is much longer than that observed in
patients with reverse transcription inhibition monother-
apy [7]. The reappearance of viral load during HAART is
not only due to escape mutations [5], but can also be a
consequence of cytokine induction (such as IL2, IL6 and
TNFA, see [2]) of latently infected cells in which provirus
could replicate within the lysogenic infection cycle.
In [7], the authors propose an extended differential equation
model where programmed expansion and contraction of
latently infected cells upon cytokine induction explains
the existence of viral blips (short-termed viremia above
the level of detectability) and replication of reemerging viral
strains without fully depleting the latent reservoir. A key
point of the model is the splitting of the latently infected cell
population into a resting and an activated class. For particular
time intervals, resting cells change into activated latently
infected cells. The difference of activation points of the time
intervals are assumed to be normally distributed such that,
on average, every 50 days the latent reservoir is reactivated.
Reactivated cells undergo a burst of proliferation and differ-
entiation and most of them die quickly due to the cytopathic
effects of the virus; on the other hand, it is known that after
antigen exposure host transcription factors may contribute to
an extinction of HIV-1 gene expression [20] and a part of the
cell population may revert back to the resting state [21]. In
[15] it was shown that the size of the latent reservoir depends
critically on the rate of proliferation of activated latently
infected cells. Therefore, only a model where the death rate
of infected cells is proportional to the frequency of infected
cells results in equilibrium cell populations that are stable for
the maximal clinically attainable drug efficacy parameter of
e = 0.85. In light of recent clinical studies [22] suggesting a
functional cure for some HIV infected subjects with early
HAART therapy, the ordinary differential equation (ODE)
models are not satisfactory, since they require continuous
highly efficient therapy for maintaining viral control and
predict unstable latent reservoirs once patients are off
therapy.
Alternatives to ODE models of HIV latency:
stochastic branching
Recently Conway and Coombs [23] suggested a simple
stochastic branching process to model the reactivation of
latently infected CD4+ T cell populations. For each time
point, one considers the probability that a latently infected
cell will become reactivated at the consecutive time point.
The same principle is applied to other relationships among
viral, latent and infected compartments. In this way oneCurrent Opinion in Virology 2013, 3:402–407 obtains a collection of time-dependent transition probabil-
ities which obey the so-called Chapman–Kolmogorov
equation (see [24]). Solutions to this equation determine
the extinction probability of latently infected cells. In [23]
it is shown that, under the hypothesis of non-negligible
reseeding, highly efficient HAART entails a high extinc-
tion probability of the latent reservoir within the first 20
years. On the other hand, this model also suggests that even
under perfectly efficient drug treatment, it takes several
decades for the latent reservoir to reach extinction with
probability of one. As expected, the time evolution of viral
load in this model decreases as drug efficacy increases. The
fact that viral blips occur with positive probability (with
average duration of about three days) despite efficient drug
treatment, suggests that such blips have limited clinical
significance [25] and do not represent the evolution of the
latent viral reservoir.
Provirus reactivation in HIV: feedback
regulation circuit models
Focusing on reactivation of latently infected cells, Wein-
berger and Shenk [26] provide a circuit model explain-
ing the role of transcriptional positive feedback of the
HIV transactivator of transcription (Tat) in establishing,
maintaining and resolving latent infection. The Tat
protein controls whether latently infected cells will reen-
ter the lytic infection cycle. Tat enhances transcriptional
elongation from the HIV-1 promoter, first in a deacety-
lated state to recruit transcription elongation factors, and
secondly in an acetylated state to recruit chromatin-
remodeling complexes to the long terminal repeat. In a
positive feedback loop, Tat upregulates its own expres-
sion, and its splice variant’s gene expression, which
eventually exports unspliced HIV mRNA from the
nucleus of the resting cells such that lytic replication
can restart. On the other hand, deactivation of Tat is
necessary for establishing and maintaining proviral
latency [27]. This apparent discrepancy is overcome by
introducing auto-regulatory circuits [26]: A monostable
and noncooperative feedback-resistor model explains the
off-state stability of Tat necessary for proviral latency. In
the mathematical model, the protein translation is split
into an acetylated and a deacetylated state which may
transit between each other via histone acetyltransferase
and other molecular interconversions, such that the Tat
feedback loop is monostable and can rest in an off state
even when stochasticity may perturb stability. In [26],
the authors argue that this mechanism may explain why
latent reservoirs may persist over a long period of time and
that chromatin regulation has to play an important part in
reactivation (see also Eilebrecht et al. in this issue of
Current Opinion in Virology).
Episomal latency: Herpes simplex virus
epidemiology via delay differential equations
Herpes simplex virus is transmitted by close physical
contact and reactivates regularly during the host’s lifewww.sciencedirect.com
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Disease progression during HIV infection is the result of reactivation of
latent reservoirs which may lead to viral rebound despite a long period of
nondetectability (below 50 copies/ml) during clinical latency.span. Being in a state of episomal latency in neurons, it
lacks direct integration of the viral genome into the host
cell DNA. The considerable intercellular delay from
reactivation [28] in neurons to reaching epithelial cells
makes it difficult to apply the ODE models known from
HIV infection. However, in taking an epidemiological
point of view, ODE models [29,30] (with susceptible,Figure 4
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The role of mathematical modeling as part of an iterative scheme involving 
www.sciencedirect.com infected and latent subjects as compartments) success-
fully identify the basic reproduction number that deter-
mines whether the infected population approaches an
endemic level (under the crucial assumption of exponen-
tially distributed infectious and relapse periods). Delay
differential equations (DDE) allow for more general
dynamics of the latent subpopulation. In [11], the authors
introduce an integral operator to model the proportion of
latently infected individuals given by an auxiliary time-
dependent function that describes the fraction of latently
infected individuals remaining in the latent compartment
at a particular number of time units after having entered
the compartment. DDE are mathematically more intri-
cate since a stable equilibrium (for the ODE) may
become unstable (for the DDE) and make population
sizes fluctuate. In [31,11], a condition is described under
which the DDE nevertheless is globally asymptotically
stable in that either the basic reproduction number or the
average fraction of latently infected individuals remaining
over time has to be strictly less than one. Numerical
simulations show that after beginning oscillations the
latent population reaches its equilibrium in finite time.
From the point of view of public health policy, DDE
based models provide intervention strategies aiming for
an early establishment of low basic reproduction numbers
in order to guarantee for asymptotic stability even if the
epidemiological data alone would not be sufficient to
support such measures.ts
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clinical and virological data.
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In this review we have given an overview of differential
equation models for cellular population dynamics in viral
latency with the emphasis on population stability under
presumed drug efficacy. Although many mathematical
models give promising insights into how sensitively latent
reservoirs may evolve under diminishing treatment ef-
ficacy, cohort studies [32,22] show that the genetic back-
ground of the subjects, treatment timing and dosage and
many undisclosed epigenetic factors result in a wide
variety of possible dynamics. Bridging the gap between
mathematical models and growing cohort data sets will be
a necessary step toward accurate predictive models in
light of personalized and efficient therapy intervention.
With the advent of deep sequencing, high read coverage
of RNA makes it possible to characterize viral RNA
populations at a considerable level of precision [33].
For mathematical modeling, new opportunities arise to
apply contemporary mathematical tools such as dynami-
cal systems (of quasi-species) with state-dependent tran-
sition rates (accounting for differences in host response to
particular viral RNA populations).
From a systems biology perspective, modeling epigenetic
control and its impact on reactivation of dormant provirus
constitutes the biggest challenge [13]. We suggest the use
of probabilistic tools to model epigenetically controlled
reactivation. Traditionally, mathematical models of HIV
infection such as described in [15,34] concern the evol-
ution of cell populations and viral load but neglect gene
regulatory mechanisms such as chromatin modification of
the HIV promoter [35], miRNAs [36,37] or lncRNAs [13]
that impact the reactivation of latent viral reservoirs. We
suggest a new DDE model based on the differential
equations models in [10] by adding
dT 
dt
¼ ð1  hÞeTV  dTT þ
aL
Z t
0
ProbaðXt ¼ tjX0 ¼ t0ÞLðt  tÞ dt
The probability kernel Proba is derived from the Cox–
Ross–Rubinstein process Xt [38], which is a stochastic
process reverting back to its mean value on the long run
and almost never reaches zero.
The function Proba gives the probability of resting
latently infected cells getting activated at time t with
delay t between zero and t. In [39] it was observed that
gamma-distributed delay kernels were close to exper-
imental data for intercellular delay after initial HIV in-
fection. In its stationary regime, the Cox–Ross–
Rubinstein process is gamma-distributed, and the pro-
posed model thus concerns out-of-equilibrium states of
the dynamical system after the eclipse phase (see
Figure 3). Therein latently infected cells are supposedCurrent Opinion in Virology 2013, 3:402–407 to release reactivated provirus with a time delay t that is
given by the probability of the stochastic process.
Incorporating mechanisms of transcriptional silencing
due to continuously modifying chromatin states into a
cell population model is one of the many challenges to
address in the context of viral latency models (see
Figure 4). Furthermore, next-generation sequencing
shows promising new insights for determining the role
of noncoding RNAs in the host response to HIV infection
[40]. Bringing mathematics, genomics and virology
together by developing data driven models of viral
latency shall enable clinicians to accurately design treat-
ments and come closer to the goal of eventually eradicat-
ing or silencing latent viral reservoirs.
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